Group 1 - Hong Kong Stock Exchange is considering shortening the settlement cycle from "T+2" to "T+1" to enhance liquidity and accelerate capital turnover [1] - The U.S. House of Representatives passed a significant bill regulating "stablecoins," marking a step towards integrating digital assets into the mainstream financial system [2] - The Nasdaq China Golden Dragon Index rose by 1.2%, with notable gains in U.S. stocks, including Nvidia, which reached a market capitalization of over $4.2 trillion [3] Group 2 - BlackRock reported that over 20% of its clients are considering reducing exposure to the U.S. market and dollar assets, with a focus on Asian stock opportunities [4] - The Ministry of Finance in China adjusted the consumption tax policy for ultra-luxury cars, now applying to vehicles retailing at 900,000 yuan and above [5] Group 3 - Shanghai's brain-computer interface research achieved a breakthrough, allowing 10 subjects to communicate their thoughts through a computer interface, potentially benefiting patients with speech impairments [6] - Southern Power Grid reported a new peak load of 256 million kilowatts due to high temperatures, marking the second highest load this year [7] Group 4 - The price of silicon wafers has increased significantly, with N-type G10L single crystal silicon wafers rising by 22.09% to 1.05 yuan per piece [8][9] - Changjie Tong expects a profit of 31 to 37 million yuan for the first half of the year, with cloud subscription revenue projected to grow by over 10% [10] Group 5 - Yanzhou Coal Mining Company reported a coal production of 73.6 million tons in the first half of the year, a year-on-year increase of 6.54% [11] - Friendship Time anticipates a mid-term revenue growth of approximately 14.1% to 23.6%, with profits expected to increase significantly [12] Group 6 - Yuan Da Pharmaceutical's nasal spray product for treating dry eye syndrome has received approval for commercialization in mainland China [13] - The Chinese online literature market is projected to reach a revenue of 49.55 billion yuan in 2024, with a year-on-year growth of 29.37% [14] Group 7 - China Power plans to acquire a 31% stake in Tori Power for approximately 310 million yuan [15] - Baiyunshan's research on Ganoderma lucidum spore oil for treating lung nodules has been published in a prominent scientific journal [16] Group 8 - Tigermed plans to sell a 3.41% stake in Lixin Pharmaceutical for approximately 34.11 million USD [17][18] - Lens Technology is reportedly considering reviving its IPO plans in Hong Kong [19] Group 9 - Hengrui Medicine received approval for clinical trials for four new drugs, with significant investments in their development [20] - MicroPort Medical anticipates a net loss of no more than 125 million yuan for the first half of the year, with a revenue growth of 70% to 80% [21] Group 10 - Huajian Medical is launching a global exchange focused on high-tech medical innovation assets and a stablecoin plan [22] - GCL-Poly Energy has reached a strategic cooperation agreement with China Pacific Insurance Asset Management to explore tokenization solutions for real-world assets [23] Group 11 - Kingboard Laminates' major shareholder plans to place 78.5 million shares at a price of 10 HKD each [24][25] - October Rice anticipates a net profit growth of at least 90% for the first half of the year [26]
智通港股早知道 | 南方电网负荷再创新高 美国众议院通过三项加密货币法案
Zhi Tong Cai Jing·2025-07-17 23:43